Rest Of Asia Pacific IVD Labware Market (2025-2030)
The Rest Of Asia Pacific IVD Labware Market was valued at $105.4 Million in 2025 and projected to reach to $142.3 Million by 2030, representing a compound annual growth rate of 6.2%. The Rest Of Asia Pacific IVD Labware Market is poised for steady expansion driven by accelerating healthcare modernization initiatives and increasing diagnostic testing demand across emerging economies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific IVD Labware Market Trends and Insights
- Rest Of Asia Pacific is experiencing steady demand for in vitro diagnostic labware driven by increasing healthcare infrastructure investments and rising diagnostic testing volumes across emerging economies.
- The region's growth trajectory reflects expanding laboratory capabilities and heightened focus on disease detection and prevention initiatives throughout 2025–2030. Rest Of Asia Pacific's IVD labware sector benefits from improving access to diagnostic services and growing adoption of automated laboratory systems.
- The market in Rest Of Asia Pacific is characterized by a mix of established and emerging players competing to meet rising demand from hospitals, diagnostic centers, and research institutions.
- Regulatory harmonization efforts and technology transfer initiatives are further supporting market expansion in Rest Of Asia Pacific during the forecast period..
Key Market Statistics
- CAGR (2025-2030) 6.2% CAGR
- Market Size, 2025 ~USD 105.4 Million
- Forecast, 2030 ~USD 142.3 Million
- Country Rest Of Asia Pacific
Rest Of Asia Pacific IVD Labware Market Overview
Market Size & Growth :
Rest Of Asia Pacific IVD Labware Market valued at USD 105.4 million in 2025, expanding at 6.2% CAGR through 2030 to reach USD 142.3 million, outpacing global average of 6%.
Healthcare Infrastructure Expansion :
Emerging economies across Rest Of Asia Pacific investing heavily in diagnostic laboratory infrastructure, driving demand for quality IVD labware products and solutions.
Rising Diagnostic Testing Volumes :
Increased prevalence of chronic diseases and growing awareness of preventive healthcare in Rest Of Asia Pacific countries fueling higher volumes of in vitro diagnostic testing.
Market Consolidation Opportunities :
Fragmented market landscape in Rest Of Asia Pacific presents significant consolidation and partnership opportunities for regional and international IVD labware manufacturers.
Rest Of Asia Pacific IVD Labware Market Dynamics
- Government investments in laboratory infrastructure, coupled with rising healthcare expenditure and disease prevalence, are creating favorable conditions for market growth.
- The region's growing middle-class population and improving access to diagnostic services further support market expansion. Key growth drivers include expanding hospital networks, rising adoption of advanced diagnostic technologies, and increasing focus on early disease detection.
- However, regulatory variations across countries and supply chain challenges may impact growth trajectories.
- Strategic partnerships and localized product offerings will be critical for market participants seeking to capitalize on the region's growth potential through 2030..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Rest Of Asia Pacific IVD Labware Market valued at USD 105.4 million in 2025, expanding to USD 142.3 million by 2030 at 6.2% CAGR
- Rest Of Asia Pacific benefits from rising diagnostic testing volumes and healthcare infrastructure modernization across emerging economies
- Automation adoption and laboratory efficiency improvements are key growth drivers in Rest Of Asia Pacific
- Rest Of Asia Pacific market remains competitive with mixed presence of multinational and regional players
IVD Labware Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PIPETTES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | PLASTIC LABWARE (Product) |
| Market Size Base Year (Billions) | ~USD 3.77 (2025) |
| Revenue Forecast (Billions) | ~USD 5.04 (2030) |
| Segments Covered | Product, Type, Application |
Rest Of Asia Pacific IVD Labware Market Report Segmentation
3 segment dimensions are covered across the global market.
By Product
- Glass Labware
- Other Ivd Labware Products
- Plastic Labware
By Type
- Beakers & Flasks
- Cell Culture Plates
- Centrifuge/Microcentrifuge Tubes
- Cryovials/Storage Vials
- Culture Tubes
- Deep-Well Plates For Sample Preparation/Extraction
- Microplates
- Other Glass Labware Products
- Other Plastic Labware Products
- Other Plates
- Other Tubes
- Pcr Plates
- Pcr Tubes
- Petri Dishes & Cuvettes
- Pipettes
- Plates
- Reusable Labware
- Single-Use Labware
- Slides & Coverslips
- Test Tubes
- Tubes
- Vials
By Application
- Clinical Chemistry
- Hematology
- Immunoassays
- Microbiology
- Molecular Diagnostics
- Other Applications
Target Audience
- IVD Labware Manufacturers : Require regional market sizing, growth forecasts, and competitive dynamics to develop targeted expansion strategies and product localization plans for Rest Of Asia Pacific markets.
- Healthcare System Operators : Need market intelligence on labware demand trends and infrastructure investment patterns to optimize procurement strategies and laboratory equipment planning across the region.
- Medical Device Distributors : Seek detailed market forecasts and growth driver analysis for Rest Of Asia Pacific to identify high-potential territories and develop effective distribution and sales strategies.
- Private Equity & Investment Firms : Require comprehensive market data and growth projections for Rest Of Asia Pacific to evaluate investment opportunities and assess acquisition targets in the IVD labware sector.
- Healthcare Consultants & Advisors : Need region-specific market insights and forecasts to provide strategic recommendations to clients on market entry, expansion, and competitive positioning in Rest Of Asia Pacific.
Key Companies in the Rest Of Asia Pacific IVD Labware Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| AVANTOR, INC. | United States | Public Company | Materials and consumables,Equipment and instrumentation,Services and specialty procurements, |
| CORNING INCORPORATED | United States | Public Company | Optical Communications (fiber, cable, hardware),Display Glass Substrates (LCD, OLED),Specialty Materials & Mobile Consumer Electronics, |
| EPPENDORF SE | Germany | Private Company | Liquid handling (pipettes, dispensers, automated systems),Separation & instrumentation (centrifuges, PCR cyclers, ULT freezers),Bioprocess solutions (fermenters, bioreactors, single-use), |
| TARSONS PRODUCTS LIMITED | India | Public Company | General labware (bottles, carboys, boxes, racks, volumetric reusables),Tubes, vials, sampling aids, cryoware, centrifuge ware,Cell culture ware, genomics and PCR consumables, proteomics/immunology-focused items, |
| SARTORIUS AG | Germany | Public Company | Bioprocess solutions (bioreactors, filtration, fluid management, process chromatography),Cell culture solutions (media, reagents, supplements, nucleic acid delivery, cell lines),Analytical solutions (BLI, cytometry, PAT, live-cell imaging, SPR), |
| ABBOTT LABORATORIES | United States | Public Company | Diagnostic Products,Medical Devices,Nutritional Products, |
| QIAGEN N.V. | Netherlands | Public Company | Sample technology consumables and instruments,Immune response and infectious disease diagnostics,Oncology and sexual and reproductive health assays, |
| SYSMEX CORPORATION | Japan | Public Company | Hematology analyzers and reagents (XN-Series, XN-V, ProCyte Dx),Coagulation diagnostics,Blood gas, electrolyte, and urinalysis systems, |
| SCG PACKAGING PUBLIC COMPANY LIMITED | Thailand | Public Company | Fiber packaging (corrugated, containerboard, coated duplex, sack kraft, liners),Consumer and performance packaging (flexible and rigid, including medical and labware),Fibrous business (pulp, food service, paper products), |
| AZENTA, INC. | United States | Public Company | Sample Management Solutions,Multiomics (genomic and related analysis services), |
| BRAND GROUP | Israel | Public Company | Infrastructure (roads, rail, tunnels, bridges, runways, lighting),Engineering & Metal Construction for Energy and Petrochemical Facilities,Software, Control, and Ticketing Systems, |
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 that employs 125,000 people. The company operates as a major provider of laboratory equipment, reagents, and services for scientific research and diagnostics.
AVANTOR, INC.
Avantor, Inc. is a United States public company founded in 1904 with 13,500 employees. The company supplies specialty chemicals, materials, and equipment to the life sciences and advanced technology industries.
CORNING INCORPORATED
Corning Incorporated is a United States public company founded in 1851 with 67,200 employees. The company manufactures specialty glass, ceramics, and related materials for laboratory, industrial, and consumer applications.
EPPENDORF SE
Eppendorf SE is a German private company founded in 1945 with 4,358 employees. The company designs and manufactures laboratory equipment and consumables for life sciences research and diagnostics.
TARSONS PRODUCTS LIMITED
Tarsons Products Limited is an Indian public company founded in 1983 with 906 employees. The company manufactures laboratory plastic consumables and equipment for scientific and medical applications.
SARTORIUS AG
Sartorius AG is a German public company founded in 1870 with 14,242 employees. The company provides laboratory and process technologies, including weighing, filtration, and bioprocess equipment.
ABBOTT LABORATORIES
Abbott Laboratories is a United States public company founded in 1888 with 115,000 employees. The company develops and manufactures pharmaceuticals, diagnostics, medical devices, and nutritional products.
QIAGEN N.V.
QIAGEN N.V. is a Netherlands-based public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics and life sciences research products.
SYSMEX CORPORATION
Sysmex Corporation is a Japanese public company founded in 1968 with 10,861 employees. The company manufactures diagnostic equipment and reagents for hematology, hemostasis, and clinical chemistry testing.
SCG PACKAGING PUBLIC COMPANY LIMITED
SCG Packaging Public Company Limited is a Thai public company founded in 1975 with 6,121 employees. The company manufactures packaging materials and containers for various industrial and consumer applications.
AZENTA, INC.
Azenta, Inc. is a United States public company founded in 1978 with 2,900 employees. The company provides sample management and storage solutions for life sciences research and clinical laboratories.
BRAND GROUP
Brand Group is an Israeli public company founded in 1977 with 4,092 employees. The company manufactures laboratory plastic consumables and equipment for scientific research and diagnostics.
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Accurate market valuation for Rest Of Asia Pacific (USD 105.4M in 2025) with detailed 5-year projections enabling precise budget allocation and revenue forecasting for regional operations.
- Growth Driver Analysis : Comprehensive insights into healthcare infrastructure investments and diagnostic testing volume trends specific to Rest Of Asia Pacific, identifying high-potential market segments and opportunities.
- Competitive Landscape Intelligence : Detailed understanding of market consolidation opportunities and fragmented competitive dynamics in Rest Of Asia Pacific, supporting strategic positioning and partnership decisions.
- Regulatory & Market Entry Insights : Country-specific regulatory variations and market entry barriers across Rest Of Asia Pacific economies, reducing risk and accelerating go-to-market strategies for new products.
- Strategic Planning & Investment Decisions : Data-driven insights for capital allocation, expansion planning, and M&A strategies tailored to Rest Of Asia Pacific's unique market dynamics and growth trajectory through 2030.
Frequently asked questions
What is the current market size of IVD Labware in Rest Of Asia Pacific?
Rest Of Asia Pacific IVD Labware Market is estimated at USD 105.4 million in 2025.
What is the projected market size for Rest Of Asia Pacific by 2030?
Rest Of Asia Pacific IVD Labware Market is forecasted to reach USD 142.3 million by 2030.
What is the CAGR for Rest Of Asia Pacific IVD Labware Market?
Rest Of Asia Pacific IVD Labware Market is expected to grow at a CAGR of 6.2% from 2025 to 2030.
What factors are driving growth in Rest Of Asia Pacific?
Rest Of Asia Pacific growth is driven by increasing healthcare infrastructure investments, rising diagnostic testing volumes, automation adoption, and regulatory harmonization efforts.
Who are the key players in Rest Of Asia Pacific IVD Labware Market?
Rest Of Asia Pacific market comprises a mix of multinational corporations and regional players competing across hospitals, diagnostic centers, and research institutions.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, restraints, challenges, and key player strategies. To track company developments, such as acquisitions, product launches, expansions, agreements, and partnerships, the competitive landscape of the IVD labware is analyzed to evaluate market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources primarily consisted of industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of the industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Thermo Fisher Scientific Inc. |
Sales Manager |
|
Tarsons Products Ltd. |
Area Sales Manager |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the IVD labware market’s total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the IVD labware market have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
IVD Labware Market: Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
IVD (in vitro diagnostics) labware refers to plastic, glass, or other consumables used in diagnostic testing. These products enable the collection, handling, and processing of human biological samples for disease detection and analysis. IVD labware plays a vital role across major diagnostic applications such as immunoassays, clinical chemistry, molecular diagnostics, hematology, and microbiology.
Key Stakeholders
- Manufacturers & Distributors of IVD Labware
- IVD Companies
- Hospitals
- Clinical Laboratories
- Academic Institutes
- Public Health Laboratories
- Ambulatory Surgical Centers
- Market Research & Consulting Firms
- Government Associations
- Venture Capitalists & Investors
Report Objectives
- To define, describe, segment, and forecast the global IVD labware by product, type, application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall IVD labware
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the IVD labware using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Available Customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the IVD labware market
Company profiles
- Additional five company profiles of players operating in the IVD labware market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the IVD labware market
Get the Full IVD Labware Market Report
Full forecast, segment splits, and company analysis for all IVD Labware Market.
- US IVD Labware Market
- Canada IVD Labware Market
- Germany IVD Labware Market
- UK IVD Labware Market
- France IVD Labware Market
- Italy IVD Labware Market
- Spain IVD Labware Market
- China IVD Labware Market
- Japan IVD Labware Market
- India IVD Labware Market
- Brazil IVD Labware Market
- Mexico IVD Labware Market
- UAE IVD Labware Market
- Rest Of Europe IVD Labware Market
- Rest Of Latin America IVD Labware Market
- Kingdom Of Saudi Arabia IVD Labware Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report